The global vaccine adjuvants market size reached US$ 884 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,812 Million by 2028, exhibiting a growth rate (CAGR) of 12.4% during 2023-2028. More Info:- https://www.imarcgroup.com/vaccine-adjuvants-market

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Vaccine Adjuvants
Market Research and
Forecast Report 2023-2028
Author: Elena Anderson,
Marketing Manager |
IMARC Group
© 2019 IMARC All Rights Reserved

2. Report Description
About IMARC Group
The International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all sectors
and regions to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
Global Vaccine Adjuvants Market Research Report:
The latest report by IMARC, titled “Vaccine Adjuvants Market: Global Industry Trends, Share, Size,
Growth, Opportunity and Forecast 2023-2028” finds that the global vaccine adjuvants market size
reached US$ 884 Million in 2022.
Vaccine adjuvants are compounds that improve the body’s immunogenic response against antigens.
They increase the ability of the vaccines to induce long-term protection against infections. Presently,
aluminum salts and MF59 are the only adjuvants found fit for human use.
In recent years, the demand for vaccine adjuvants has escalated as they increase antibody titers,
reduce required antigen doses, induce a rapid immune response and long-lasting memory, and
enhance the immune response in the elderly and young children.
Request Free Sample Report: https://www.imarcgroup.com/vaccine-adjuvants-
market/requestsample

4. Report Description
Report Description and Highlights
Global Vaccine Adjuvants Market Trends:
One of the primary factors driving the market is the rising incidences of infectious diseases and allergies, such as
human immunodeficiency virus (HIV/AIDS), cancer, human papillomavirus (HPV), and tuberculosis. Additionally, the
need for advanced treatment options for prevailing and emerging fatal diseases has increased the need to develop
vaccines possessing long-lasting effects on immunization. Other than this, governments of numerous nations are
taking initiatives for immunization and improvements in adjuvants for human consumption.
They are also focusing on enhancing the healthcare infrastructure and increasing investments in research and
development (R&D) of new therapeutics, which is creating a positive market outlook. Furthermore, with the sudden
coronavirus (COVID-19) outburst, the demand for effective and safe vaccine adjuvants is constantly increasing. On
account of these factors, IMARC Group expects the market value to reach US$ 1,812 Million by 2028, expanding at a
CAGR of 12.4% during the forecast period (2023-2028).
Looking forward, the market value is projected to reach a strong growth during the forecast period
(2023-2028).

5. Report Description
Report Description and Highlights
Market Summary:
Breakup by Product Type:
• Adjuvant Emulsions
• Pathogen Components
• Particulate Adjuvants
• Combination Adjuvants
• Others
Breakup by Route of Administration:
• Oral
• Intramuscular
• Intranasal
• Subcutaneous
• Intradermal
• Others
Breakup by Diseases:
• Cancer
• Infectious Diseases

6. Report Description
Report Description and Highlights
• Others
Breakup by Application:
• Research
• Commercial
Breakup by Region:
• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany

7. Report Description
Report Description and Highlights
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

8. Competitive Landscape with Key Players:
• Adjuvance Tecchnologies Inc.
• Adjuvatis
• Agenus Inc.
• Brenntag SE
• Chemtrade Logistics Inc.
• CSL Limited
• Croda International Plc
• Invivogen
• Novavax Inc.
• OZ Biosciences
• Virometix AG
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/vaccine-adjuvants-market
Report Description
Report Description and Highlights

9. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

10. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

11. Report Description
Report Description and Highlights
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

12. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us